BRIEF published on 02/28/2025 at 19:33, 1 year 6 months ago Adocia Completes €9.7 Million Private Placement Private Placement Share Capital Biopharmaceutical Diabetes Treatment ADOCIA
PRESS RELEASE published on 02/28/2025 at 19:28, 1 year 6 months ago Inside Information / Other news releases Adocia successfully settles and delivers €9.7 million private placement, issuing 2,125,000 new ordinary shares with warrants. Admittance to trading on Euronext Paris confirmed Private Placement Euronext Paris Diabetes Biopharmaceutical ADOCIA
BRIEF published on 02/26/2025 at 08:47, 1 year 6 months ago ADOCIA strengthens its cash flow with a private placement of 9.7 million euros Private Placement Capital Increase Biopharmaceutical Third Party Capital Financial Tonnage
PRESS RELEASE published on 02/26/2025 at 08:42, 1 year 6 months ago Inside Information / Operations of the issuer (acquisitions, sales...) Adocia successfully completes €9.7 million private placement, extending cash runway to Q2 2026. New shares issued with warrants attached. Notable investors include Gerard Soula and Armistice Capital Private Placement Investors New Shares Cash Runway ADOCIA
BRIEF published on 02/25/2025 at 19:08, 1 year 6 months ago Adocia: Financial report for the fourth quarter of 2024 Diabetes Treasury Partnership ADOCIA BioChaperone®
PRESS RELEASE published on 02/25/2025 at 19:03, 1 year 6 months ago Inside Information / News release on accounts, results Adocia reports Q4 2024 financial results, €7.5M cash position, partnership updates with Sanofi, and business priorities. Strong revenue growth detailed in press release Financial Results Revenue Growth ADOCIA Partnership Updates Business Priorities
BRIEF published on 02/11/2025 at 14:03, 1 year 7 months ago Threshold crossing at ADOCIA by the CDC Actions Threshold Crossing Bpifrance ADOCIA Deposit Fund
BRIEF published on 12/23/2024 at 18:40, 1 year 8 months ago Adocia announces its participation in key conferences in 2025 Investors Biopharmaceutical ADOCIA Conférences 2025 Diabetes And Obesity
BRIEF published on 08/30/2024 at 08:05, 2 years ago ADOCIA: Information on shares and voting rights as of July 31, 2024 Voting Rights Actions Biopharmaceutical July 31, 2024 ADOCIA
Published on 09/18/2026 at 14:30, 16 minutes ago AIAI Holdings to Obtain a Controlling Position in Messier 42 Marketing Agreement
Published on 09/18/2026 at 13:30, 1 hour 16 minutes ago Alset AI Provides Shareholder Update, Announces Updated Investor Presentation and Appoints Mitchell Jackman as Chief Financial Officer
Published on 09/18/2026 at 06:30, 8 hours 16 minutes ago GREE Chairperson Dong Mingzhu Honored by UNEP Cool Coalition for Leadership in Sustainable Cooling
Published on 09/18/2026 at 00:55, 13 hours 51 minutes ago Tectonic Metals Announces Results of the 2026 Annual General Meeting
Published on 09/18/2026 at 14:25, 21 minutes ago Huawei Unveils Innovative Immersive Telepresence Solution That Offers Immersive Experiences and Intelligent Services
Published on 09/18/2026 at 13:52, 54 minutes ago New rules for green claims. Does eco-friendly also mean animal-friendly?
Published on 09/18/2026 at 13:51, 54 minutes ago Completion of the Acquisition of a Majority Stake in Jucari Global Pty Ltd
Published on 09/18/2026 at 13:50, 56 minutes ago Omio expands premium overnight travel options with Twiliner
Published on 09/18/2026 at 13:30, 1 hour 16 minutes ago EQS-Adhoc: Sibanye Gold Limited: Notice to Bondholders
Published on 09/17/2026 at 17:40, 21 hours 6 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 21 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 2 days 7 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
